Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-23

Study Completion Date

2026-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research concerns the study of language disorders of patients present in the spectrum of psychosis. It is indeed accepted that psychotic disorders are associated with language difficulties, which are only poorly highlighted thanks to reusable tools in clinical practice. These language disorders impact communication, and concern many linguistic domains, thus covering phonology, lexicon, semantics, morphosyntax and pragmatics. It therefore seems relevant to characterize these language disorders and to assess to what extent they interact with the other symptoms of the pathology, in particular the course of the thought disorder and the neuropsychological symptoms. In addition, this study is particularly interested in the interactions between working memory capacities and those related to syntax. It is intended for different patients suffering from psychotic disorders of different intensities, treated in the Psychotherapeutic Center of Nancy. Patients suffering from at-risk mental state (ARMS), first episode of psychosis (FEP) or schizophrenia will benefit from a complete language assessment, evaluating each domain mentioned above, on the expressive and understanding sides. The results of the language assessment will be compared with those of a control group in the same tests. They will also be analyzed with regard to the neuropsychological and psychiatric elements noted in the patient's medical file, in order to highlight possible associations between language skills, neuropsychological and psychiatric symptoms in this patient population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders

NCT05742893

Psychotic Disorders

COMPLETED NA

Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age

NCT04280367

Schizophrenia Learning Disorders Executive Function Disorders

COMPLETED

Linguistic Predictors of Outcomes in Psychosis

NCT05601050

Schizophrenia and Related Disorders

COMPLETED

Study on Communication Comprehension in the Schizophrenic Spectrum

NCT03225027

Schizophrenia Simple

COMPLETED NA

Semantic and Syntactic Computerized Analysis of Free Speech

NCT03525054

Psychotic Disorders Psychosis Schizophrenia and Related Disorders +2 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychosis Schizophrenia At-risk Mental State Language Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

early psychotic symptoms

This group includes patients with ARMS and those with FEP. Although they are not in the same place in the continuum of psychosis, these patients benefit from the same language assessment and CAST, do not benefit from the TLC or the MINI, and the data from their neuropsychological and psychiatric assessment will be used , which is why we have chosen to bring them together in the same arm. They are between 16 and 35 years old and are cared for as part of their usual follow-up at the CPN (Nancy Psychotherapeutic Center). They must have received the diagnosis of ARMS and FEP according to the criteria of CAARMS and SPI-A.

Group Type EXPERIMENTAL

Language assessment

Intervention Type BEHAVIORAL

The proposed speech and language therapy assessment will consist of a battery of standardized tests that speech and language therapists can use to assess the language skills in reception and expression of adult patients.

Concerning the assessment of the interactions between working memory and semantic abilities, a complete protocol has been developed.

CAST - Cannabis Abuse Screening Test

Intervention Type COMBINATION_PRODUCT

The purpose of this questionnaire is to approximate participants' cannabis consumption and to assess any disorders associated with cannabis consumption. It will be offered to all participants, patients and healthy controls

patients with schizophrenia

The schizophrenic patients group will benefit from language assessment, TLC and CAST. They are between 18 and 55 years old and are cared for as part of their usual follow-up at the CPN. They must have been diagnosed with schizophrenia according to DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) criteria.

Group Type EXPERIMENTAL

Language assessment

Intervention Type BEHAVIORAL

The proposed speech and language therapy assessment will consist of a battery of standardized tests that speech and language therapists can use to assess the language skills in reception and expression of adult patients.

Concerning the assessment of the interactions between working memory and semantic abilities, a complete protocol has been developed.

TLC - Scale for the Assessment of Thought, Language, and Communication

Intervention Type BEHAVIORAL

This scale is frequently used in psychiatry and is used to measure formal thought disorders in patients suffering from psychosis. As part of this study, it will be intended for patients suffering from schizophrenia

CAST - Cannabis Abuse Screening Test

Intervention Type COMBINATION_PRODUCT

The purpose of this questionnaire is to approximate participants' cannabis consumption and to assess any disorders associated with cannabis consumption. It will be offered to all participants, patients and healthy controls

healthy controls

The control group for this study will be made up of volunteers between the ages of 16 and 55, not suffering from any mental disorder detected on the MINI or from a developmental disorder of oral or written language. They will also benefit from an assessment of cannabis use using the CAST.

Group Type EXPERIMENTAL

Language assessment

Intervention Type BEHAVIORAL

The proposed speech and language therapy assessment will consist of a battery of standardized tests that speech and language therapists can use to assess the language skills in reception and expression of adult patients.

Concerning the assessment of the interactions between working memory and semantic abilities, a complete protocol has been developed.

MINI - Mini International Neuropsychiatric Interview

Intervention Type BEHAVIORAL

This scale corresponds to a rapid assessment of the psychiatric and psychological state of patients. It helps detect any psychiatric disorders. Here, it will be offered to volunteers who are part of the control group.

CAST - Cannabis Abuse Screening Test

Intervention Type COMBINATION_PRODUCT

The purpose of this questionnaire is to approximate participants' cannabis consumption and to assess any disorders associated with cannabis consumption. It will be offered to all participants, patients and healthy controls

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Language assessment

The proposed speech and language therapy assessment will consist of a battery of standardized tests that speech and language therapists can use to assess the language skills in reception and expression of adult patients.

Concerning the assessment of the interactions between working memory and semantic abilities, a complete protocol has been developed.

Intervention Type BEHAVIORAL

TLC - Scale for the Assessment of Thought, Language, and Communication

This scale is frequently used in psychiatry and is used to measure formal thought disorders in patients suffering from psychosis. As part of this study, it will be intended for patients suffering from schizophrenia

Intervention Type BEHAVIORAL

MINI - Mini International Neuropsychiatric Interview

This scale corresponds to a rapid assessment of the psychiatric and psychological state of patients. It helps detect any psychiatric disorders. Here, it will be offered to volunteers who are part of the control group.

Intervention Type BEHAVIORAL

CAST - Cannabis Abuse Screening Test

The purpose of this questionnaire is to approximate participants' cannabis consumption and to assess any disorders associated with cannabis consumption. It will be offered to all participants, patients and healthy controls

Intervention Type COMBINATION_PRODUCT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Speech and language therapy assessment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All Groups:

* Patient affiliated or entitled to a social security scheme
* Patient having received informed information on the study and having co-signed, with the investigator, a consent to participate in the study
* For minor participants, at least one of the parents or holders of parental authority having been informed of the study, having received the information note relating to it and not having objected to the participation of his or her child
* Native language: French
* ARMS and FEP Patient Group:

* Age between 16 and 35 years old
* Present the criteria for EMRP or FEP as defined by the Comprehensive Assessment of At Risk Mental State (CAARMS) or present the criteria for Disorders of the course of thought to the items of the Schizophrenia Proneness Instrument (SPI-A)
* Patients with schizophrenia group:

* Age between 16 and 55 years old
* Patient with diagnostic criteria for schizophrenia, as defined by DSM V (American Psychiatric Association, 2015)
* Present the criteria for Disorganization of Speech and Formal Thought Disorder as defined by the Thinking, Language and Communication (TLC) Rating Scale.
* Healthy Volunteers Group:

* Age between 16 and 55 years old
* Parental authorization (of both parents) to participate in the study for minor patients

Exclusion Criteria

* All groups:

* Pregnant, parturient or nursing mother
* Person deprived of liberty by a judicial or administrative decision
* Person in a life-threatening emergency
* Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
* Adult person unable to express their consent and who is not the subject of a legal protection measure
* Impairment of the subject making it difficult, if not impossible, for them to participate in the trial or to understand the information given to them
* Abuse or dependence of any substance according to DSM V criteria excluding cannabis
* Healthy Volunteers Group:

* Evolving psychiatric pathology (axis I of the DSM IV, measured at the MINI) excluding anxiety disorder
* Presence of developmental disorder of oral language or written language revealed on clinical examination.

Minimum Eligible Age

16 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes